Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor

Journal of Clinical Investigation

Volumn 104, Issue 9, 1999, Pages 1213-1221

  Fischer, Edgar G ^a,d   Riewald, Matthias ^b   Huang, Hui Yu ^b   Miyagi, Yohei ^c   Kubota, Yoshinobu ^c   Mueller, Barbara M ^b   Ruf, Wolfram ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; BLOOD CLOTTING FACTOR 7A; HEPARIN; INTEGRIN; PROTEINASE; PROTEOGLYCAN; RECEPTOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 0032699212     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7750     Document Type: Article

References (35)

1. Mignatti, P., and Rifkin, D.B. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:161-195.
2. Johnsen, M., Lund, L.R., Romer, J., Almholt, K., and Dano, K. 1998. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10:667-671.
3. Powell, W.C., and Matrisian, L.M. 1996. Complex roles of matrix metalloproteinases in tumor progression. Curr. Top. Microbiol. Immunol. 213:1-22.
4. Ruf, W., and Edgington, T.S. 1994. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 8:385-390.
5. Callander, N.S., Varki, N., and Rao, L.V.M. 1992. Immunohistochemical identification of tissue factor in solid tumors. Cancer. 70:1194-1201.
6. Shoji, M., et al. 1998. Activation of coagulation and angiogenesis in cancer. Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am. J. Pathol. 152:399-411.
7. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029-1038.
8. Broze, G.J. 1995. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu. Rev. Med. 46:103-112.
9. Sprecher, C.A., Kisiel, W., Mathewes, S., and Foster, D.C. 1994. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc. Natl. Acad. Sci. USA. 91:3353-3357.
10. Miyagi, Y., et al. 1994. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. J. Biochem. (Tokyo). 116:939-942.
11. Petersen, L.C., et al. 1996. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry. 35:266-272.
12. Bromberg, M.E., Konigsberg, W.H., Madison, J.F., Pawashe, A., and Garen, A. 1995. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA. 92:8205-8209.
13. Mueller, B.M., and Ruf, W. 1998. Requirement for binding of catalytically active factor VIIa in tissue factor dependent experimental metastasis. J. Clin. Invest. 101:1372-1378.
14. Ott, I., Fischer, E.G., Miyagi, Y., Mueller, B.M., and Ruf, W. 1998. A role for tissue factor in cell adhesion and migration mediated by interaction with actin binding protein 280. J. Cell Biol. 140:1241-1253.
15. Cunningham, C.C., et al. 1992. Actin-binding protein requirement for cortical stability and efficient locomotion. Science. 255:325-327.
16. Wei, Y., et al. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
17. Brooks, P.C., et al. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell. 85:683-693.
18. Diaz-Collier, J.A., et al. 1994. Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli. Thromb. Haemost. 71:339-346.
19. Werb, Z., Tremble, P.M., Behrendtsen, O., Crowley, E., and Damsky, C.H. 1989. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109:877-890.
20. Sato, Y., et al. 1997. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb. Haemost. 78:1138-1141.
21. Sevinsky, J.R., Rao, L.V.M., and Ruf, W. 1996. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J. Cell Biol. 133:293-304.
22. Drake, T.A., Morrissey, J.H., and Edgington, T.S. 1989. Selective cellular expression of tissue factor in human tissues. Am. J. Pathol. 134:1087-1097.
23. Novotny, W.F., Brown, S.G., Miletich, J.P., Rader, D.J., and Broze, G.J., Jr. 1991. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood. 78:387-393.
24. Müller, M., et al. 1999. Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells. Exp. Cell Res. 248:136-147.
25. Sorensen, B.B., et al. 1999. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J. Biol. Chem. 274:21349-21354.
26. Huang, Z.-F., Higuchi, D., Lasky, N., and Broze, G.J., Jr. 1997. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 90:944-951.
27. Brown, L.F., et al. 1993. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143:1255-1262.
28. Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S., and Fusenig, N.E. 1997. Halting angiogenesis suppresses carcinoma cell invasion. Nat. Med. 3:1222-1227.
29. Zetter, B.R. 1998. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49:407-424.
30. Callander, N.S., et al. 1992. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J. Biol. Chem. 267:876-882.
31. Wesselschmidt, R., Likert, K., Huang, Z., MacPhail, L., and Broze, G.J., Jr. 1993. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coagul. Fibrinolysis. 4:661-669.
32. r 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch. Biochem. Biophys. 335:82-92.
33. Randolph, G.J., Luther, T., Albrecht, S., Magdolen, V., and Muller, W.A. 1998. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood. 92:4167-4177.
34. Dennis, M.S., and Lazarus, R.A. 1994. Kunitz domain inhibitors of tissue factor-factor VIIa. I. Potent inhibitors selected from libraries by phage display. J. Biol. Chem. 269:22129-22136.
35. Iino, M., Foster, D.C., and Kisiel, W. 1998. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler. Thromb. Vasc. Biol. 18:40-46.